Myovant Sciences Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 579

Employees

  • Latest Deal Type
  • 2ndary - Open

  • Financing Rounds
  • 6

Myovant Sciences General Information

Description

Provider of drug discovery and development services intended to redefine care for women and men through purpose-driven science.

Contact Information

Website
www.myovant.com
Formerly Known As
Roivant Endocrinology
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 2000 Sierra Point Parkway
  • 9th Floor
  • Brisbane, CA 94005
  • United States
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Acquirer
Sumitomo Pharma
Vertical(s)
Life Sciences, Oncology
Former Stock Listing
MYOV
Corporate Office
  • 2000 Sierra Point Parkway
  • 9th Floor
  • Brisbane, CA 94005
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Myovant Sciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Myovant Sciences‘s full profile, request access.

Request a free trial

Myovant Sciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of drug discovery and development services intended to redefine care for women and men through purpose-driven s
Biotechnology
Brisbane, CA
579 As of 2022

New York, NY
 

South San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Myovant Sciences Competitors (24)

One of Myovant Sciences’s 24 competitors is Roivant Sciences, a Formerly PE-Backed company based in New York, NY.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Roivant Sciences Formerly PE-Backed New York, NY
Genentech Formerly VC-backed South San Francisco, CA
Renova Therapeutics Venture Capital-Backed Carlsbad, CA
Merck & Co. Corporation Rahway, NJ
Cardior Formerly VC-backed Hannover, Germany
You’re viewing 5 of 24 competitors. Get the full list »

Myovant Sciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Myovant Sciences Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Myovant Sciences‘s full profile, request access.

Request a free trial

Myovant Sciences FAQs

  • When was Myovant Sciences founded?

    Myovant Sciences was founded in 2016.

  • Where is Myovant Sciences headquartered?

    Myovant Sciences is headquartered in Brisbane, CA.

  • What is the size of Myovant Sciences?

    Myovant Sciences has 579 total employees.

  • What industry is Myovant Sciences in?

    Myovant Sciences’s primary industry is Biotechnology.

  • Is Myovant Sciences a private or public company?

    Myovant Sciences is a Private company.

  • What is the current valuation of Myovant Sciences?

    The current valuation of Myovant Sciences is .

  • What is Myovant Sciences’s current revenue?

    The current revenue for Myovant Sciences is .

  • How much funding has Myovant Sciences raised over time?

    Myovant Sciences has raised $358M.

  • Who are Myovant Sciences’s investors?

    BB Biotech, Hercules Capital (San Mateo), NovaQuest Capital Management, Pfizer, and Roivant Sciences are 5 of 6 investors who have invested in Myovant Sciences.

  • Who are Myovant Sciences’s competitors?

    Roivant Sciences, Genentech, Renova Therapeutics, Merck & Co., and Cardior are some of the 24 competitors of Myovant Sciences.

  • When was Myovant Sciences acquired?

    Myovant Sciences was acquired on 10-Mar-2023.

  • Who acquired Myovant Sciences?

    Myovant Sciences was acquired by Sumitomo Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process